Elsevier/MEDai,
a leading clinical analytics & transformational services solutions
provider, is inviting your organization to participate in our upcoming
product evaluation study for our next-generation, real-time predictive
analytics solution. Pinpoint Review 2 is designed to provide bedside care providers and Quality Department personnel with inpatient-specific, clinically meaningful risk predictions. For each individual inpatient, you will be able to identify risk levels and risk trending for five critical outcomes: • Risk of excessive Length of Stay • Risk of Transfer to ICU during hospitalization • Risk of 30 Day Readmission following discharge • Risk of Sepsis during hospitalization • Risk of Mortality during hospitalization Deployed on an iPad™, Pinpoint Review 2 empowers providers to evaluate these five individual inpatient risks right at the bedside and while moving from room to room and unit to unit. Patient lists are simply and rapidly customized by the user, allowing Case Managers, Hospitalists and Intensivists, Nurse Managers, Charge Nurses, and Quality Department personnel to view selected inpatient units or the entire inpatient population. Join us at 1PM Eastern on December 4th for this webinar, where Dr. Peter Edelstein, Chief Medical Officer of Elsevier/MEDai, Monica Lovelace, Director of Strategic Accounts, and Dr. Anton Berisha, Director of Clinical Analytics will provide attendees with an in-depth overview of our upcoming Pinpoint Review 2 Product Evaluation Study. |
||||||||||||
Interested attendees would include:
Attendees would represent organizations including:
|
||||||||||||
|
||||||||||||
Return to HealthExecWire Archive Menu
|